JP2009512624A5 - - Google Patents

Download PDF

Info

Publication number
JP2009512624A5
JP2009512624A5 JP2008515804A JP2008515804A JP2009512624A5 JP 2009512624 A5 JP2009512624 A5 JP 2009512624A5 JP 2008515804 A JP2008515804 A JP 2008515804A JP 2008515804 A JP2008515804 A JP 2008515804A JP 2009512624 A5 JP2009512624 A5 JP 2009512624A5
Authority
JP
Japan
Prior art keywords
isopropyl
oxo
oct
amide
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008515804A
Other languages
English (en)
Japanese (ja)
Other versions
JP5086248B2 (ja
JP2009512624A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/021765 external-priority patent/WO2006133104A2/en
Publication of JP2009512624A publication Critical patent/JP2009512624A/ja
Publication of JP2009512624A5 publication Critical patent/JP2009512624A5/ja
Application granted granted Critical
Publication of JP5086248B2 publication Critical patent/JP5086248B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008515804A 2005-06-07 2006-06-06 5−ht4受容体アゴニストとしてのベンゾイミダゾロン−カルボキサミド化合物 Expired - Fee Related JP5086248B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68804805P 2005-06-07 2005-06-07
US60/688,048 2005-06-07
PCT/US2006/021765 WO2006133104A2 (en) 2005-06-07 2006-06-06 Benzoimidazolone-carboxamide compounds as 5-ht4 receptor agonists

Publications (3)

Publication Number Publication Date
JP2009512624A JP2009512624A (ja) 2009-03-26
JP2009512624A5 true JP2009512624A5 (cg-RX-API-DMAC7.html) 2009-07-02
JP5086248B2 JP5086248B2 (ja) 2012-11-28

Family

ID=37499008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008515804A Expired - Fee Related JP5086248B2 (ja) 2005-06-07 2006-06-06 5−ht4受容体アゴニストとしてのベンゾイミダゾロン−カルボキサミド化合物

Country Status (7)

Country Link
US (2) US7317022B2 (cg-RX-API-DMAC7.html)
EP (1) EP1902053B1 (cg-RX-API-DMAC7.html)
JP (1) JP5086248B2 (cg-RX-API-DMAC7.html)
AT (1) ATE495171T1 (cg-RX-API-DMAC7.html)
DE (1) DE602006019595D1 (cg-RX-API-DMAC7.html)
ES (1) ES2359673T3 (cg-RX-API-DMAC7.html)
WO (1) WO2006133104A2 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
DE602005014566D1 (de) * 2004-11-05 2009-07-02 Theravance Inc Chinolinon-carboxamid-verbindungen
DE602005016446D1 (de) * 2004-11-05 2009-10-15 Theravance Inc 5-HT4-Rezeptoragonistenverbindungen
ATE469897T1 (de) * 2004-12-22 2010-06-15 Theravance Inc Indazolcarbonsäureamidverbindungen
BRPI0608392A2 (pt) * 2005-03-02 2009-12-29 Theravance Inc compostos de quinolinona como agonistas do receptor 5-ht4
MY143574A (en) * 2005-11-22 2011-05-31 Theravance Inc Carbamate compounds as 5-ht4 receptor agonists
JPWO2009101917A1 (ja) * 2008-02-13 2011-06-09 エーザイ・アール・アンド・ディー・マネジメント株式会社 ビシクロアミン誘導体
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
CN102762572A (zh) 2010-02-01 2012-10-31 诺瓦提斯公司 作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists
RU2764243C2 (ru) 2017-09-22 2022-01-14 ДЖУБИЛАНТ ЭПИПЭД ЭлЭлСи Гетероциклические соединения в качестве ингибиторов PAD
CN111225915B (zh) 2017-10-18 2023-03-07 朱比兰特埃皮帕德有限公司 作为pad抑制剂的咪唑并吡啶化合物
US11629135B2 (en) 2017-11-06 2023-04-18 Jubilant Prodell Llc Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
RS65576B1 (sr) 2017-11-24 2024-06-28 Jubilant Episcribe Llc Heterociklična jedinjenja kao inhibitori prmt5
CN112105610B (zh) 2018-03-13 2024-01-26 朱比连特普罗德尔有限责任公司 作为pd1/pd-l1相互作用/活化的抑制剂的双环化合物
CN115073311B (zh) * 2022-03-23 2023-05-23 河南大学 一种高效制备n,n′-二(2羟乙基)苯胺的合成方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223511A (en) 1987-09-23 1993-06-29 Boehringer Ingelheim Italia S.P.A. Benzimidazoline-2-oxo-1-carboxylic acid compounds useful as 5-HT receptor antagonists
IT1231413B (it) 1987-09-23 1991-12-04 Angeli Inst Spa Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht
JP3829879B2 (ja) 1994-05-18 2006-10-04 大正製薬株式会社 キノリンカルボン酸誘導体
IT1275903B1 (it) 1995-03-14 1997-10-24 Boehringer Ingelheim Italia Esteri e ammidi della 1,4-piperidina disostituita
US6069152A (en) 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
IT1298271B1 (it) 1998-02-18 1999-12-20 Boehringer Ingelheim Italia Esteri ed ammidi dell'acido 2-oxo-2,3-diidro-benzimidazol-1- carbossilico
WO2000064441A2 (en) 1999-04-28 2000-11-02 Respiratorius Ab Compound for use as a medicament for treatment of disorders involving bronchocontraction
CN1355698A (zh) 1999-06-15 2002-06-26 呼吸器有限公司 可用作治疗有关支气管收缩的机能障碍的药物的化合物
IT1313625B1 (it) 1999-09-22 2002-09-09 Boehringer Ingelheim Italia Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.
PL1664036T3 (pl) 2003-09-03 2012-04-30 Pfizer Związki benzimidazolonu wykazujące działanie agonistyczne względem receptora 5-ht4
TW200533348A (en) 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
DE602005016446D1 (de) 2004-11-05 2009-10-15 Theravance Inc 5-HT4-Rezeptoragonistenverbindungen
DE602005014566D1 (de) 2004-11-05 2009-07-02 Theravance Inc Chinolinon-carboxamid-verbindungen
ATE469897T1 (de) 2004-12-22 2010-06-15 Theravance Inc Indazolcarbonsäureamidverbindungen

Similar Documents

Publication Publication Date Title
JP2008525466A5 (cg-RX-API-DMAC7.html)
JP2008518965A5 (cg-RX-API-DMAC7.html)
JP2007532546A5 (cg-RX-API-DMAC7.html)
JP2007523175A5 (cg-RX-API-DMAC7.html)
KR101376479B1 (ko) 뮤 오피오이드 수용체 안타고니스트인 8­아자비시클로[3.2.1]옥탄 화합물
ES2315425T3 (es) Compuestos de amonio cuaternario y su uso como agentes antimuscarinicos.
JP2009528371A5 (cg-RX-API-DMAC7.html)
CN111902146B (zh) 用于治疗咳嗽的医药品
TWI410410B (zh) Phenylacetic acid compounds
JP2008518975A5 (cg-RX-API-DMAC7.html)
HRP20120775T1 (hr) Antagonisti m3 muskarinskog acetilkolinskog receptora
JP2005533860A5 (cg-RX-API-DMAC7.html)
WO2007097197A1 (ja) アミド誘導体またはその塩
JP2011162556A5 (cg-RX-API-DMAC7.html)
JPH04308590A (ja) セロトニン拮抗体
PL200551B1 (pl) Pochodne 3-(3-izopropylo-5-metylo-4H-1,2,4-triazol-4-ilo)-egzo-8-azabicyklo[3.2.1]oktanu, środek farmaceutyczny, zastosowanie tych pochodnych oraz środka farmaceutycznego i związki pośrednie
CZ2001282A3 (en) Ligands exhibiting high affinity for ORL-1 nociceptin receptor
JP2006528617A5 (cg-RX-API-DMAC7.html)
JP2010535858A5 (cg-RX-API-DMAC7.html)
CA2598536A1 (en) Oxyindole derivatives as 5ht4 receptor agonists
US20050182089A1 (en) Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist
TW200304824A (en) Nicotinamide derivatives useful as PDE4 inhibitors
RU2006133320A (ru) Соединения индазолкарбоксамида в качестве агонистов 5-нт4 рецепторов
JP2007505931A5 (cg-RX-API-DMAC7.html)
JP2012533550A5 (cg-RX-API-DMAC7.html)